Trials / Completed
CompletedNCT06250946
Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .
A Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group Phase ⅡStudy to Evaluate the Efficacy and Safety of HRS-7535 in Obese Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 235 (actual)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this trial is to evaluate the efficacy and safety of HRS-7535 in Chinese Obese Subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-7535;Placebo | HRS-7535;Placebo |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2024-02-23
- Primary completion
- 2025-01-22
- Completion
- 2025-01-22
- First posted
- 2024-02-09
- Last updated
- 2025-04-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06250946. Inclusion in this directory is not an endorsement.